Abcellera Biologics Inc (ABCL)

10:14 AM

Truist raises AbCellera stock price target on clinical data promise By Investing.com - Investing.com Canada

10:14 AM

09:55 AM

Wall Street Analysts Believe ABCELLERA BIOLG (ABCL) Could Rally 97.28%: Here's is How to Trade - Yahoo Finance Singapore

09:55 AM

04:29 AM

ABCL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

04:29 AM

May 21, 2026

ABCL Stock Climbs As Earnings Beat, Drug Data Fuel Bullish Outlook - StocksToTrade

May 21, 2026

May 20, 2026

10 Best Penny Stocks to Buy for Long Term - Insider Monkey

May 20, 2026

May 20, 2026

Abcellera Biologics Inc at JPMorgan Healthcare Conference Transcript - GuruFocus

May 20, 2026

May 20, 2026

Abcellera Biologics Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus

May 20, 2026

May 19, 2026

AbCellera Biologics : Corporate Overview - marketscreener.com

May 19, 2026

May 19, 2026

ABCL stock clocks best week since February on clinical data anticipation, Baker Bros stake boost - MSN

May 19, 2026

May 18, 2026

AbCellera Biologics Inc.Common Shares (NQ: ABCL - FinancialContent

May 18, 2026

May 18, 2026

Director John Montalbano adds 20,000 AbCellera (ABCL) shares in open trade - Stock Titan

May 18, 2026

May 17, 2026

AbCellera Biologics Q1 earnings call highlights - MSN

May 17, 2026

May 15, 2026

Earnings Update: Here's Why Analysts Just Lifted Their AbCellera Biologics Inc. (NASDAQ:ABCL) Price Target To US$10.14 - Sahm

May 15, 2026

May 14, 2026

Jones Trading initiates coverage of AbCellera Biologics (ABCL) with buy recommendation - MSN

May 14, 2026

May 14, 2026

AbCellera Biologics Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:ABCL) 2026-05-14 - Seeking Alpha

May 14, 2026

May 14, 2026

Are Medical Stocks Lagging ABCELLERA BIOLG (ABCL) This Year? - Yahoo Finance

May 14, 2026

May 14, 2026

AbCellera Biologics Inc. (NASDAQ:ABCL) Q1 2026 Earnings Call Transcript - Insider Monkey

May 14, 2026

May 13, 2026

AbCellera Biologics Inc. (ABCL) reports Q1 loss, beats revenue estimates - MSN

May 13, 2026

May 13, 2026

ABCL: Advancing a differentiated antibody pipeline, with ABCL635 leading and key clinical readouts ahead - TradingView

May 13, 2026

May 13, 2026

ABCL: Transitioning to a clinical-stage developer, the company advances unique antibody programs with strong potential - TradingView

May 13, 2026

May 13, 2026

AbCellera Biologics (ABCL) Q4 Revenue Surge Tests High 20.1x P/S Growth Narrative - Sahm

May 13, 2026

May 12, 2026

AbCellera Moves ABCL635 Into Phase 2 As Losses Continue - Yahoo Finance

May 12, 2026

May 12, 2026

AbCellera Biologics Bets Big on 2026 Trial Catalysts - TipRanks

May 12, 2026

May 12, 2026

Q1 2026 Abcellera Biologics Inc Earnings Call Transcript - GuruFocus

May 12, 2026

May 12, 2026

ABCL Stock Holds Support As Traders Watch Biotech Rebound - StocksToTrade

May 12, 2026

May 12, 2026

AbCellera Biologics Inc (ABCL) News, Articles, Events & Latest Updates - Stocktwits

May 12, 2026

May 12, 2026

AbCellera Biologics (ABCL) Anticipates Major Developments in 202 - GuruFocus

May 12, 2026

May 12, 2026

Stifel Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Raises Target Price to $8 - Moomoo

May 12, 2026

May 12, 2026

Cantor raises AbCellera stock price target on menopause drug data By Investing.com - Investing.com Canada

May 12, 2026

May 12, 2026

Truist Financial Maintains AbCellera Biologics(ABCL.US) With Buy Rating - 富途牛牛

May 12, 2026

May 12, 2026

Stifel raises AbCellera stock price target on trial data strength By Investing.com - Investing.com Nigeria

May 12, 2026

May 12, 2026

Stifel raises AbCellera stock price target on trial data strength - Investing.com

May 12, 2026

May 12, 2026

AbCellera Biologics Q1 2026 earnings preview - MSN

May 12, 2026

May 12, 2026

JonesTrading Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Raises Target Price to $13 - 富途牛牛

May 12, 2026

May 12, 2026

AbCellera anticipates ABCL635 Phase II topline data in Q3 as it targets at least $6B US VMS market - MSN

May 12, 2026

May 12, 2026

AbCellera Biologics Q1 2026 Earnings Call Transcript - MarketBeat

May 12, 2026

May 12, 2026

AbCellera Biologics Inc (ABCL) Q1 2026 Earnings Call Highlights: Promising Advancements Amid Financial Challenges - GuruFocus

May 12, 2026

May 12, 2026

ABCL SWOT Analysis: Key Insights from 10-Q Filing - GuruFocus

May 12, 2026

May 11, 2026

AbCellera (ABCL) Reports Strong Q1 Revenue and Progress in Clini - GuruFocus

May 11, 2026

May 11, 2026

ABCL: Q1 2026 saw robust liquidity, pipeline advances, and ABCL635 phase II progress for VMS - TradingView

May 11, 2026

May 11, 2026

AbCellera Biologics Q1 Earnings Call Highlights - Barchart.com

May 11, 2026

May 11, 2026

AbCellera (ABCL) Q1 2026 Earnings Transcript - The Globe and Mail

May 11, 2026

May 11, 2026

ABCL: Q1 2026 saw doubled revenue, strong liquidity, and ABCL635 advancing to phase II with key data due Q3 - TradingView

May 11, 2026

May 11, 2026

AbCellera Biologics Q1 Loss Narrows, Revenue Rises - Moomoo

May 11, 2026

May 11, 2026

ABCL Financials: Income Statement, Balance Sheet & Cash Flow | Abcellera Biologics Inc. - Stock Titan

May 11, 2026

May 11, 2026

AbCellera reports positive phase 1 data for menopause treatment - Investing.com UK

May 11, 2026

May 11, 2026

MSN Money - MSN

May 11, 2026

May 11, 2026

Is AbCellera Biologics (ABCL) 1.2% Overvalued After Q1 2026 Resu - GuruFocus

May 11, 2026

May 11, 2026

AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance

May 11, 2026